BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1446671)

  • 21. Synthetic peptides with the biological activities and specificity of human C3a anaphylatoxin.
    Hugli TE; Erickson BW
    Proc Natl Acad Sci U S A; 1977 May; 74(5):1826-30. PubMed ID: 266705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A mechanism of action for anaphylatoxin C3a stimulation of mast cells.
    Mousli M; Hugli TE; Landry Y; Bronner C
    J Immunol; 1992 Apr; 148(8):2456-61. PubMed ID: 1373170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Active recombinant C3a of human anaphylatoxin produced in Escherichia coli.
    Fukuoka Y; Yasui A; Tachibana T
    Biochem Biophys Res Commun; 1991 Mar; 175(3):1131-8. PubMed ID: 2025244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acylation-stimulating protein (ASP): structure-function determinants of cell surface binding and triacylglycerol synthetic activity.
    Murray I; Köhl J; Cianflone K
    Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):41-8. PubMed ID: 10432298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptide analogues of the anaphylatoxin C3a; syntheses and properties.
    Ambrosius D; Casaretto M; Gerardy-Schahn R; Saunders D; Brandenburg D; Zahn H
    Biol Chem Hoppe Seyler; 1989 Mar; 370(3):217-27. PubMed ID: 2713103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The active site of C3a anaphylatoxin.
    Caporale LH; Tippett PS; Erickson BW; Hugli TE
    J Biol Chem; 1980 Nov; 255(22):10758-63. PubMed ID: 6968751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced biopotency of synthetic C3a analogues by membrane binding. A fluorescence anisotropy decay study.
    Federwisch M; Casaretto M; Gerardy-Schahn R; Bitter-Suermann D; Wollmer A
    Biophys Chem; 1992 Oct; 44(3):151-61. PubMed ID: 1420945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of C3a anaphylatoxin receptor on guinea-pig macrophages.
    Murakami Y; Imamichi T; Nagasawa S
    Immunology; 1993 Aug; 79(4):633-8. PubMed ID: 8406589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective hexapeptide agonists and antagonists for human complement C3a receptor.
    Scully CC; Blakeney JS; Singh R; Hoang HN; Abbenante G; Reid RC; Fairlie DP
    J Med Chem; 2010 Jul; 53(13):4938-48. PubMed ID: 20527893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amino acid sequence of guinea pig C3a anaphylatoxin.
    Gerard NP; Lively MO; Gerard C
    Protein Seq Data Anal; 1988; 1(6):473-8. PubMed ID: 3064079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of C3a and C5a anaphylatoxins on guinea-pig isolated blood vessels.
    Marceau F; Hugli TE
    J Pharmacol Exp Ther; 1984 Sep; 230(3):749-54. PubMed ID: 6332191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of C3a receptor-proteins on guinea pig platelets and human polymorphonuclear leukocytes.
    Gerardy-Schahn R; Ambrosius D; Saunders D; Casaretto M; Mittler C; Karwarth G; Görgen S; Bitter-Suermann D
    Eur J Immunol; 1989 Jun; 19(6):1095-102. PubMed ID: 2666143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary injury induced by C3a and C5a anaphylatoxins.
    Stimler NP; Hugli TE; Bloor CM
    Am J Pathol; 1980 Aug; 100(2):327-48. PubMed ID: 6967702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C3a receptor on dibutyryl-cAMP-differentiated U937 cells and human neutrophils: the human C3a receptor characterized by functional responses and 125I-C3a binding.
    Klos A; Bank S; Gietz C; Bautsch W; Köhl J; Burg M; Kretzschmar T
    Biochemistry; 1992 Nov; 31(46):11274-82. PubMed ID: 1332754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antifungal activity of C3a and C3a-derived peptides against Candida.
    Sonesson A; Ringstad L; Nordahl EA; Malmsten M; Mörgelin M; Schmidtchen A
    Biochim Biophys Acta; 2007 Feb; 1768(2):346-53. PubMed ID: 17169328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low zone desensitization: a stimulus-specific control mechanism of cell response. Investigations on anaphylatoxin-induced platelet secretion.
    Meuer S; Zanker B; Hadding U; Bitter-Suermann D
    J Exp Med; 1982 Mar; 155(3):698-710. PubMed ID: 6977607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of biologically active C3a as fusion proteins.
    Fukuoka Y; Tachibana T; Yasui A
    Immunol Lett; 1993 Oct; 38(2):153-8. PubMed ID: 8294143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The anaphylatoxic peptide C3a of guinea pig complement. I. Purification, physicochemical and antigenetic properties.
    Meuer S; Becker S; Hadding U; Bitter-Suermann D
    Z Immunitatsforsch Immunobiol; 1978 Mar; 154(2):135-46. PubMed ID: 77089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Active site of C3a anaphylatoxin: contributions of the lipophilic and orienting residues.
    Unson CG; Erickson BW; Hugli TE
    Biochemistry; 1984 Feb; 23(4):585-9. PubMed ID: 6608957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimation of local vital reactions in severely burned tissues of guinea pig skin using C3a or C3a desArg as a marker.
    Maeno Y; Mori Y; Iwasa M; Inoue H
    Forensic Sci Int; 1993 Sep; 61(1):43-52. PubMed ID: 8225139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.